CIBC World Market
IMGN

CIBC World Market’s Immunogen Inc IMGN Stock Holding History

CIBC World Market’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-25,520
Closed -$374K – 739
2013
Q4 		$374K Sell
25,520
-3,744
-13% -$57.5K ﹤0.01% 568
2013
Q3 		$498K Buy
29,264
+8,794
+43% +$155K ﹤0.01% 440
2013
Q2 		$340K Buy
+20,470
New +$332K ﹤0.01% 453

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Market's IMGN Position: Q1 2014 in Review

CIBC World Market sold out of Immunogen Inc (IMGN) in Q1 2014, closing a stake of 25,520 shares — an estimated $374K sold.

CIBC World Market first reported a position in IMGN in Q2 2013 and held it in 3 quarters. The position peaked at $498K in Q3 2013. 142 funds tracked by Wall St. Rank hold IMGN as of Q1 2014.

  • CIBC World Market reported no remaining Immunogen Inc position as of Q1 2014 after selling out during the quarter.
  • CIBC World Market sold 25,520 Immunogen Inc shares in Q1 2014, an estimated $374K.
  • CIBC World Market first reported a position in Immunogen Inc in Q2 2013 and held it in 3 quarters.
  • CIBC World Market's Immunogen Inc position peaked at $498K in Q3 2013.
  • 142 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2014.

Based on CIBC World Market's 13F filing for Q1 2014, filed 13 May 2014.